# ELDICO Scientific

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eldico-scientific

- Industry: Biotechnology
- Headquarters: Switzerland
- Website: www.eldico-scientific.com
- Total disclosed funding: $1.6M
- Latest round: Seed (May 6, 2020)
- Investors on record: 3

## About

ELDICO Scientific AG operates in advanced crystallographic services, emphasizing the development and application of cutting-edge electron diffraction technology to enhance structure elucidation in various scientific sectors.Founded in 2019 in Switzerland, ELDICO Scientific AG specializes in advanced electron diffraction technology, marked by its flagship product, the ELDICO ED-1. The company has not undergone any notable strategic pivots since its inception. The founders include Gunther Steinfeld, Gustavo Santiso-Quinones, and Nils Gebhardt, with Eric Hovestreydt serving as CEO. In May 2020, ELDICO raised CHF 1.5 million in a Seed funding round led by Bernina BioInvest AG, which marked its total funding raised to CHF 1.5 million, resulting in a current company valuation of CHF 6.5 million.ELDICO Scientific AG specializes in advanced crystallographic services, primarily focusing on the development and application of electron diffraction technology, specifically its flagship product, the ELDICO ED-1, the world’s first dedicated horizontal electron diffractometer. This state-of-the-art instrument, designed with Swiss precision, enables unrivaled structure elucidation of nano-sized particles, making it highly valuable in sectors such as pharmaceuticals, agrochemicals, and materials science. The ED-1 is complemented by a suite of crystallographic services that integrate advanced electron diffraction techniques with expert crystal growth methods, catering to the needs of contract research organizations (CROs), academic institutions, and industrial researchers globally, particularly in North America and Europe. Their offerings also include minimal sample requirement services, allowing for structural determination from as little as 100 micrograms, thereby addressing challenges in crystallization and analysis of complex compounds.ELDICO Scientific AG generates revenue through its comprehensive crystallographic services, structured around client partnerships with various research organizations, academic institutions, and pharmaceutical companies. Clients typically engage with ELDICO through contracts for specific projects, such as the successful crystallization and structural elucidation of compounds, often achieved in significantly shorter timeframes than traditional methods. The transaction structure generally involves service agreements that outline the terms for utilizing the ELDICO ED-1 and related analytical services, ensuring clients receive tailored solutions for their research needs. ELDICO’s revenue is bolstered by its ability to provide high-quality data and fast turnaround times, which are critical for clients engaged in rigorous R&D processes.In May 2020, ELDICO Scientific AG raised CHF 1.5 million in Seed funding to support its growth strategy, focusing on the development of new products, including enhancements to the ELDICO ED-1 and potentially new electron diffraction devices. The company aims to expand its presence in North America and Europe by targeting additional markets and establishing strategic partnerships by the end of 2023. The recent funding will be utilized to accelerate product development and market entry, ensuring ELDICO remains competitive in the evolving crystallography landscape.

## Funding rounds

- Seed, May 6, 2020, $1.6M — Aargauische Kantonalbank, Venture Kick, Bernina BioInvest AG

## Investors

- Aargauische Kantonalbank — Seed
- Venture Kick (https://capitalatlas.ai/funds/venture-kick) — Seed
- Bernina BioInvest AG — Seed